Scott & Selber, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Scott & Selber, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$478.3 - $607.98 $1.25 Million - $1.58 Million	-2,603 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$544.75 - $658.21 $38,677 - $46,732	71 Added 2.8%	2,603 $1.46 Million
Q2 2020 Aug 04, 2020	SELL	$493.32 - $643.92 $16,279 - $21,249	-33 Reduced 1.29%	2,532 $1.58 Million
Q1 2020 Apr 28, 2020	BUY	$336.18 - $494.43 $862,301 - $1.27 Million	2,565 New	2,565 $1.25 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Scott & Selber, Inc., based on Form 13F filings with the SEC.

Stay updated on Scott & Selber, Inc. with notifications on news.